GO
Loading...

Pfizer Inc

More

  • Final Glance: Pharmaceuticals companies Friday, 24 Apr 2015 | 8:08 PM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $71.14. Bristol-Myers Squibb Co. fell$. 20 or. 3 percent, to $65.80. Eli Lilly& Co. fell$. 82 or 1.1 percent, to $71.58.

  • NEW YORK, April 24- Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector. Companies reporting first-quarter earnings next week include Bristol-Meyers Squibb Co,...

  • Midday Glance: Pharmaceuticals companies Friday, 24 Apr 2015 | 1:36 PM ET

    Baxter International Inc. fell$. 39 or. 5 percent, to $71.12. Bristol-Myers Squibb Co. fell$. 28 or. 4 percent, to $65.72. Eli Lilly& Co. fell$. 98 or 1.4 percent, to $71.42.

  • Most active New York Stock Exchange-traded stocks Friday, 24 Apr 2015 | 1:36 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. AT&T Inc. rose. 1 percent to $34.27 with 24,327,600 shares traded. Bank of America Corp. fell. 3 percent to $15.65 with 22,512,500 shares traded.

  • Early Glance: Pharmaceuticals companies Friday, 24 Apr 2015 | 10:55 AM ET

    Baxter International Inc. fell$. 42 or. 6 percent, to $71.09. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $65.89. Pfizer fell$. 11 or. 3 percent, to $35.25.

  • Comcast's failed $45 billion deal for Time Warner Cable is a high-profile example of a failed deal, but it doesn't crack the list of the 10 largest. That distinction belongs to an unsolicited, $79.6 billion bid for Time Warner Inc. made by Rupert Murdoch's 21st Century Fox, according to financial data provider Dealogic. Time Warner Inc. spun off Time Warner Cable...

  • Stocks rise on tech earnings; Nasdaq adds to record Friday, 24 Apr 2015 | 4:43 AM ET

    NEW YORK— Stocks advanced slightly Friday as investors cheered the quarterly results of three large technology companies: Google, Microsoft and Amazon. Next week, more than 150 companies in the S&P 500 will report their results, including such market-moving names as Apple, Ford, Visa, Pfizer and Exxon Mobil. Microsoft, Amazon and Google all rose sharply after the...

  • LONDON, April 24- AstraZeneca has sharpened its focus on cancer drugs with two new deals as it looks beyond a hit to sales and profits from the launch of cheap copies of its popular stomach acid pill Nexium in the vital U.S. market. AstraZeneca will get an upfront payment of $450 million from Celgene, while Innate will receive an initial $250 million from...

  • Final Glance: Pharmaceuticals companies Thursday, 23 Apr 2015 | 6:05 PM ET

    Baxter International Inc. rose $1.13 or 1.6 percent, to $71.51. Bristol-Myers Squibb Co. fell$. 60 or. 9 percent, to $66.00. Eli Lilly& Co. rose$. 10 or. 1 percent, to $72.40.

  • Business events scheduled for the coming week Thursday, 23 Apr 2015 | 1:43 PM ET

    Restaurant Brands International Inc. reports quarterly financial results before the market opens. WASHINGTON— Standard& Poor's releases S&P/Case-Shiller index of home prices for February, 9 a.m.; The Conference Board releases the Consumer Confidence Index for April, 10 a.m.; Federal Reserve policymakers meet to set interest rates. WASHINGTON— Commerce...

  • Midday Glance: Pharmaceuticals companies Thursday, 23 Apr 2015 | 1:24 PM ET

    Baxter International Inc. rose $1.67 or 2.4 percent, to $72.05. Bristol-Myers Squibb Co. fell$. 54 or. 8 percent, to $66.06. Eli Lilly& Co. rose$. 25 or. 3 percent, to $72.55.

  • Early Glance: Pharmaceuticals companies Thursday, 23 Apr 2015 | 11:02 AM ET

    Baxter International Inc. rose $1.00 or 1.4 percent, to $71.38. Bristol-Myers Squibb Co. fell$. 63 or. 9 percent, to $65.97. Eli Lilly& Co. fell$. 98 or 1.4 percent, to $71.32.

  • April 23- A unit of AstraZeneca Plc has teamed up with Juno Therapeutics Inc to develop combination treatments that use the body's immune system to kill cancer cells. The partnership between AstraZeneca's research and development arm MedImmune and Juno is the latest collaboration between companies intent on developing a new class of drugs known as...

  • April 23- Investment bank and asset manager Lazard Ltd reported a better-than-expected quarterly profit as a jump in corporate dealmaking boosted its M&A advisory fees. M&A and other advisory fees for Lazard, the sole adviser to H.J. Some of the other ongoing big deals that Lazard is part of include AT&T Inc's $67.1 billion bid for DirecTV and Pfizer Inc's $17...

  • April 23- Investment bank and asset manager Lazard Ltd reported a better-than-expected quarterly profit as a jump in corporate dealmaking boosted its M&A advisory fees. M&A and other advisory fees for Lazard, the sole adviser for H.J. The other ongoing big deals that Lazard is part of include AT&T Inc's $67.1 billion bid for DIRECTV and Pfizer Inc's $17 billion...

  • Final Glance: Pharmaceuticals companies Wednesday, 22 Apr 2015 | 6:13 PM ET

    Baxter International Inc. rose$. 33 or. 5 percent, to $70.38. Bristol-Myers Squibb Co. fell$. 21 or. 3 percent, to $66.60. Hospira rose$. 04 or percent, to $87.80.

  • Midday Glance: Pharmaceuticals companies Wednesday, 22 Apr 2015 | 1:39 PM ET

    Baxter International Inc. fell$. 12 or. 2 percent, to $69.93. Bristol-Myers Squibb Co. fell$. 21 or. 3 percent, to $66.60. Eli Lilly& Co. fell$. 02 or percent, to $72.19.

  • Early Glance: Pharmaceuticals companies Wednesday, 22 Apr 2015 | 10:25 AM ET

    Baxter International Inc. rose$. 11 or. 2 percent, to $70.16. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $66.70. Eli Lilly& Co. rose$. 09 or. 1 percent, to $72.30.

  • LONDON, April 22- Swiss drugmaker Roche has "renewed confidence" that drugs targeting potentially brain-destroying plaque can fight Alzheimer's disease, following promising results with a product from a rival. Pharmaceuticals head Daniel O'Day said on Wednesday Roche would look again at prospects for two of its experimental Alzheimer's drugs, both of...

  • US cancer center, software firm make deals in Cuba Tuesday, 21 Apr 2015 | 6:58 PM ET
    New York Governor Andrew Cuomo sits inside a vintage US car in Havanna on April 20, 2015.

    A cancer research center and a software company reached agreements with Cuban partners during a two-day trade mission to Cuba.